A cadre of the procuratorate who had symptoms of cardiovascular disease unfortunately passed away because he was busy with work and neglected medical treatment; A young man under the age of 30 had a heart attack due to long-term bad living habits...... Whenever he talks about the patients with cardiovascular diseases he has come into contact with, Fan Jihai, director of the Department of Cardiovascular Medicine of Suzhou BOE Hospital, is full of sadness and regret.

Cardiovascular disease (CVD) is a major chronic non-communicable disease that threatens human life and health worldwide. According to the data of the "40 China Cardiovascular Health and Disease Report", the number of patients with cardiovascular diseases in China has reached 00 million. Among them, atherosclerotic cardiovascular disease (ASCVD) is the leading cause of death among urban and rural residents, with ASCVD occurring from two out of every five deaths. "Dyslipidemia is an important factor that induces a variety of cardiovascular and cerebrovascular chronic diseases, and the incidence of hyperlipidemia in the population is as high as 0%, and the age of onset is younger." Fan Jihai pointed out that compared with chronic diseases such as hypertension and hyperglycemia, at present, the awareness rate and treatment rate of hyperlipidemia in China are at a low level, and long-term and standardized blood lipid management is the key to avoid a variety of cardiovascular diseases induced by hyperlipidemia.

血脂異常堪稱“隱形殺手”，忽視血脂管理加劇致病隱患

Dyslipidemia is an abnormally high level of lipid components such as cholesterol, triglycerides, and low-density lipoprotein in the blood, or an abnormally low level of high-density lipoprotein. Fan Jihai said that in addition to inducing atherosclerotic cardiovascular disease, dyslipidemia may also cause coronary heart disease, stroke, peripheral artery disease, etc., and is closely related to diabetes complications, pancreatitis and other diseases, which can be called the "hidden killer" of cardiovascular health.

(Fan Jihai, director of the Department of Cardiovascular Medicine of Suzhou BOE Hospital, photo provided by the interviewee)

Although dyslipidemia can induce a variety of cardiovascular diseases, there is still a lack of clear public awareness of its severity. "There are many patients who have obvious symptoms of cardiovascular disease in the first few visits, but most patients will not adhere to long-term and standardized blood lipid management due to work and life reasons." Fan Jihai pointed out that the neglect and misalignment of patients' cognition of the disease will not only miss the best time for treatment, but also further aggravate the hidden dangers of disease due to their own wrong living habits.

Fan Jihai reminded that key groups with family history, hypertension or diabetes, long-term high-intensity work, high-oil and high-sugar diet, alcoholism, lack of exercise, and staying up late for a long time should pay more attention to blood lipid management. This group of people should first be intervened through TLC (therapeutic lifestyle modification), including reducing the intake of saturated fatty acids and cholesterol, reducing weight through regular exercise, etc., and in the case of TLC failing to resolve dyslipidemia, drug intervention is required according to their own blood lipid indexes and under the advice of a doctor.

The prevention and treatment situation of dyslipidemia is severe, and long-term standardized drug treatment is very important

According to the "Chinese Guidelines for the Management of Blood Lipids (50 Years)", the low-density lipoprotein cholesterol (LDL-C) of ultra-high-risk groups should be less than 0.0mmol/L, and the reduction rate from baseline should be greater than 0%, but the current disease prevention and treatment goals of dyslipidemia people have a long way to go. "Poor medication compliance is a major difficulty in the management of blood lipids in patients at present." Wang Qiang, director of the pharmacy department of Suzhou BOE Hospital, said that there are a variety of lipid-lowering drugs on the market, which either reduce the level of low-density finger protein in the body or inhibit the absorption of cholesterol in the intestine, so as to achieve the goal of reducing blood lipid levels. However, due to the large number of lipid-lowering drugs on the market and the large variety of drugs, it also causes difficulties in regular and quantitative medication for patients, especially middle-aged and elderly patients.

(Wang Qiang, director of the pharmacy department of Suzhou BOE Hospital, photo provided by the interviewee)

"Clinically, such as very high-risk patient populations, the combination drug regimen is relatively speaking, and the lipid-lowering effect is better." Fan Jihai said that taking ezetimibe atorvastatin calcium tablets (II) as an example, this compound preparation combines statins and ezetimibe into two lipid-lowering ingredients, which reduces the dosage and economic burden of patients while improving patients' medication compliance.

據悉，該藥物於 2024 年納入醫保目錄，自今年1月正式啟用後，蘇州京東方醫院已可正常開具，價格降幅約近七成，極大減輕患者經濟負擔。

The rapid introduction of Guotan medicine has demonstrated its advantages, and the non-public medical force has benefited more patients

With the optimization and improvement of the medical system, as an important part of China's medical and health undertakings, a more flexible operating mechanism and market-oriented ability have made non-public medical forces play an increasingly important role. Wang Qiang introduced that the drug introduction process of Suzhou BOE Hospital is simple, and the rapid introduction of drugs can be realized through the online pharmaceutical affairs meeting, and the drug price is the same as that of public hospitals, which will benefit patients with cardiovascular diseases with "good medical insurance" in the first time. In addition, the hospital can also flexibly purchase original drugs or centralized collection of drugs according to the needs of patients to achieve precise medical services.

(Suzhou BOE Hospital, courtesy of the hospital)

In addition, non-public medical forces also provide "meticulous" services in terms of public medical security. Fan Jihai pointed out that "Suzhou BOE Hospital attaches great importance to the follow-up system, taking cardiovascular diseases as an example, doctors and nurses form a follow-up team to go deep into the surrounding communities of the hospital to establish health records for residents, monitor blood pressure, blood lipids, blood sugar and other indicators, and adjust the treatment plan in a timely manner according to the feedback data." Through high-frequency follow-up, we can establish a good and strong emotional bond with patients, and improve patients' recognition of the hospital and treatment compliance. The hospital also took the initiative to assume social responsibility, continued to carry out large-scale health science education and free clinic services, and established the first "Suzhou First Aid Knowledge and Skills Camp" to effectively improve the public's awareness and literacy of emergency medical science.

據瞭解，今年1月，蘇州京東方醫院獲評三級綜合醫院，未來，醫院將持續整合高端醫療資源、開展定製化診療服務，打造特色醫療服務平臺，滿足市民多層次、多元化就醫需求。